Compile Data Set for Download or QSAR
Report error Found 100 Enz. Inhib. hit(s) with all data for entry = 12411
TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701209(4-[2-(N-[(1S)-3,3-difluorocyclohexyl]anilino)- 2-o...)
Affinity DataKi:  0.114nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM50622931(CHEMBL5409738 | US12122750, Example 44)
Affinity DataKi:  0.311nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM50622929(CHEMBL5416925 | US12122750, Example 11)
Affinity DataKi:  0.336nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM50622932(CHEMBL5400661 | US12122750, Example 53)
Affinity DataKi:  0.342nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM50622930(CHEMBL5408779 | US12122750, Example 32)
Affinity DataKi:  0.345nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM50622927(CHEMBL5430412 | US12122750, Example 2)
Affinity DataKi:  0.352nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM50622928(CHEMBL5430333 | US12122750, Example 7)
Affinity DataKi:  0.382nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701241(4-[2-(N-(3,3-difluorocyclohexyl)anilino)-2- oxo-et...)
Affinity DataKi:  0.383nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701184(4-[2-(N-cyclohexyl-3-fluoro-anilino)-2-oxo- ethyl]...)
Affinity DataKi:  0.400nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701213(4-[2-(2-fluoro-N-(2-fluorophenyl)anilino)-2- oxo-e...)
Affinity DataKi:  0.409nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701176(1-[methyl(phenyl)carbamoyl]-4-[2-oxo-2-(N- phenyla...)
Affinity DataKi:  0.428nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701218(4-[2-(N-(3,3-difluorocyclohexyl)anilino)-2- oxo-et...)
Affinity DataKi:  0.471nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701169(4-[2-(N-cyclohexylanilino)-2-oxo-ethyl]-1-[(2- flu...)
Affinity DataKi:  0.521nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701179(1-[(4-fluorophenyl)-methyl-carbamoyl]-4-[2- (N-(3-...)
Affinity DataKi:  0.573nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701219(4-[2-(N-(3,3-difluorocyclohexyl)-2-fluoro- anilino...)
Affinity DataKi:  0.580nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701233(4-[2-(N-(3,3-difluorocyclohexyl)anilino)-2- oxo-et...)
Affinity DataKi:  0.619nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701187(4-[2-(N-(4-fluorophenyl)anilino)-2-oxo-ethyl]- 1-[...)
Affinity DataKi:  0.716nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701181(4-[2-(N-(3-fluorophenyl)anilino)-2-oxo-ethyl]- 1-[...)
Affinity DataKi:  0.774nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701180(1-[(4-fluorophenyl)-methyl-carbamoyl]-4-[2- [N-(m-...)
Affinity DataKi:  0.823nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701208(4-[2-(N-[(1R)-3,3-difluorocyclohexyl]anilino)- 2-o...)
Affinity DataKi:  0.899nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701196(1-[(4-fluorophenyl)-methyl-carbamoyl]-4-[2- [N-(o-...)
Affinity DataKi:  0.987nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701194(4-[2-(N-(3,3-difluorocyclohexyl)anilino)-2- oxo-et...)
Affinity DataKi:  1.03nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701231(4-[2-(N-(3,3-difluorocyclohexyl)anilino)-2- oxo-et...)
Affinity DataKi:  1.04nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701229(4-[2-(N-(3,3-difluorocyclohexyl)anilino)-2- oxo-et...)
Affinity DataKi:  1.04nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701239(4-[2-(N-(3,3-difluorocyclohexyl)anilino)-2- oxo-et...)
Affinity DataKi:  1.09nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701230(4-[2-(N-(3,3-difluorocyclohexyl)anilino)-2- oxo-et...)
Affinity DataKi:  1.19nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701243(4-(2-((3,3-difluorocyclohexyl)(phenyl)amino)- 2-ox...)
Affinity DataKi:  1.28nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701214(1-(6-cyanoindoline-1-carbonyl)-4-[2-(N-(3,3- diflu...)
Affinity DataKi:  1.34nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701199(1-[cyclopropyl-(4-fluorophenyl)carbamoyl]-4- [2-(N...)
Affinity DataKi:  1.37nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701217(1-[(4-cyclopropylphenyl)methyl]-4-[2-(N-(3,3- difl...)
Affinity DataKi:  1.38nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701170(4-[2-(N-cyclohexylanilino)-2-oxo-ethyl]-1- [methyl...)
Affinity DataKi:  1.44nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701211(1-[(4-cyclopropylphenyl)-methyl-carbamoyl]-4- [2-o...)
Affinity DataKi:  1.55nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701167(4-[2-(N-(2,2-difluorocyclohexyl)anilino)-2- oxo-et...)
Affinity DataKi:  1.56nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701172(4-[2-(N-cyclohexylanilino)-2-oxo-ethyl]-1- [ethyl-...)
Affinity DataKi:  1.69nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701173(4-[2-(N-cyclohexylanilino)-2-oxo-ethyl]-1- [cyclop...)
Affinity DataKi:  1.76nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701188(4-[2-(N-(4-chlorophenyl)anilino)-2-oxo-ethyl]- 1-[...)
Affinity DataKi:  1.89nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701190(1-(6-cyanoindoline-1-carbonyl)-4-[2-(N- cyclohexyl...)
Affinity DataKi:  1.94nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701221(4-[2-(N-(3,3-difluorocyclohexyl)-4-fluoro- anilino...)
Affinity DataKi:  2nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701177(4-[2-(N-(1-cyclopropylcyclopropyl)anilino)-2- oxo-...)
Affinity DataKi:  2.11nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701205(4-[2-[N-(1-cyclopropylethyl)anilino]-2-oxo- ethyl]...)
Affinity DataKi:  2.19nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701234(4-[2-(N-(3,3-difluorocyclohexyl)anilino)-2- oxo-et...)
Affinity DataKi:  2.31nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701232(4-[2-(N-(3,3-difluorocyclohexyl)anilino)-2- oxo-et...)
Affinity DataKi:  2.55nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701171(4-[2-(N-cyclohexylanilino)-2-oxo-ethyl]-1-[(4- met...)
Affinity DataKi:  2.58nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701166(4-[2-(N-cyclopentylanilino)-2-oxo-ethyl]-1-[(4- fl...)
Affinity DataKi:  2.62nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701212(1-[(4-cyclopropylphenyl)-methyl-carbamoyl]-4- [2-o...)
Affinity DataKi:  2.68nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701182(1-[(4-fluorophenyl)-methyl-carbamoyl]-4-[2- (N-(3-...)
Affinity DataKi:  2.70nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701192(4-[2-(N-(3,3-difluorocyclohexyl)anilino)-2- oxo-et...)
Affinity DataKi:  2.79nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701198(1-[cyclopropyl-(4-fluorophenyl)carbamoyl]-4- [2-ox...)
Affinity DataKi:  2.82nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701204(4-[2-[N-(1-cyclopropylethyl)anilino]-2-oxo- ethyl]...)
Affinity DataKi:  2.93nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

TargetType-2 angiotensin II receptor(Human)
Eli Lilly

US Patent
LigandPNGBDBM701235(4-[2-(N-(3,3-difluorocyclohexyl)anilino)-2- oxo-et...)
Affinity DataKi:  2.93nMAssay Description:Receptor binding affinities (Ki) were determined from a competitive radioligand binding assay with human recombinant ([125I]-Tyr4)-Angiotensin-II (22...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
2/24/2025
Entry Details
Go to US Patent

Displayed 1 to 50 (of 100 total ) | Next | Last >>
Jump to: